Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2025-12-25 @ 2:01 AM
NCT ID:
NCT05503160
Eligibility Criteria:
Inclusion Criteria:
* primary, hormone-sensitive breast cancer
* indication for adjuvant endocrine therapy (aromatase-inhibitor, tamoxifen, GnRH-analogue allone or in combination with tamoxifen/ aromatas inhibitor; combination of endocrine therapy with CDK 4/6-inhibitor/ antibody therapy/ radiotherapy)
* start of endocrine therapy \<= 3 months ago
* patients with public health ensurance
* patients who are legally competent and able to understand and follow instructions of the study staff
* present informed consent
Exclusion Criteria:
* no use of internet or digital applications
* advanced, metastatic breast cancer
* simultaneous serious disease
* life expectancy \< 2 years
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT05503160
Study Brief:
Protocol Section:
NCT05503160